The degree of thrombocytopenia in individuals with RUNX1 mutations is typically mild to moderate and can vary widely even within affected families from individuals with a normal platelet count, to severe thrombocytopenia, to childhood MDS/AML at the time of first evaluation. The gene discussed is RUNX1; the disease is myelodysplastic syndrome.